JP2024524215A - Nlrp3阻害剤を調製するための方法 - Google Patents
Nlrp3阻害剤を調製するための方法 Download PDFInfo
- Publication number
- JP2024524215A JP2024524215A JP2023578919A JP2023578919A JP2024524215A JP 2024524215 A JP2024524215 A JP 2024524215A JP 2023578919 A JP2023578919 A JP 2023578919A JP 2023578919 A JP2023578919 A JP 2023578919A JP 2024524215 A JP2024524215 A JP 2024524215A
- Authority
- JP
- Japan
- Prior art keywords
- group
- typically
- solvent
- piperidine
- protected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/04—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups from amines with formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/56—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/98—Nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202141028180 | 2021-06-23 | ||
| IN202141028180 | 2021-06-23 | ||
| PCT/EP2022/067126 WO2022268935A2 (en) | 2021-06-23 | 2022-06-23 | Novel process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024524215A true JP2024524215A (ja) | 2024-07-05 |
| JP2024524215A5 JP2024524215A5 (cg-RX-API-DMAC7.html) | 2025-06-27 |
Family
ID=82458485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023578919A Pending JP2024524215A (ja) | 2021-06-23 | 2022-06-23 | Nlrp3阻害剤を調製するための方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240150291A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4359385A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024524215A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240024842A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118019727A (cg-RX-API-DMAC7.html) |
| AR (1) | AR126215A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022300325A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3219597A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL308071A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023014547A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202317514A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022268935A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240148839A (ko) * | 2022-02-15 | 2024-10-11 | 에프. 호프만-라 로슈 아게 | 1,2,3,5,6,7-헥사히드로-s-인다센 유도체 제조를 위한 공정 |
| EP4638422A1 (en) * | 2022-12-23 | 2025-10-29 | F. Hoffmann-La Roche AG | Proccesses for the preparation of an nlrp3 inhibitor |
| WO2025036914A1 (en) | 2023-08-16 | 2025-02-20 | F. Hoffmann-La Roche Ag | Process for the preparation of preparing 1-ethyl-n-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)piperidine-4-sulfonamide |
| TW202545527A (zh) | 2024-01-16 | 2025-12-01 | 英商諾得瑟拉公司 | Nlrp3及glp-1a組合療法 |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH059102A (ja) * | 1990-09-26 | 1993-01-19 | Takeda Chem Ind Ltd | 除草剤 |
| JPH0586055A (ja) * | 1991-01-24 | 1993-04-06 | Ishihara Sangyo Kaisha Ltd | 置換ピリジンスルホンアミド系化合物、それらの製造方法及びそれらを含有する除草剤 |
| WO2010097087A1 (en) * | 2009-02-25 | 2010-09-02 | H. Lundbeck A/S | Catecholamine derivatives and prodrugs thereof |
| WO2019008025A1 (en) * | 2017-07-07 | 2019-01-10 | Inflazome Limited | NOVEL CARBOXAMIDE SULFONAMIDE COMPOUNDS |
| WO2019211463A1 (en) * | 2018-05-04 | 2019-11-07 | Inflazome Limited | Novel compounds |
| CN111393415A (zh) * | 2020-04-30 | 2020-07-10 | 苏州信诺维医药科技有限公司 | 一种杂芳腈类化合物及其应用 |
| WO2020157069A1 (en) * | 2019-01-28 | 2020-08-06 | NodThera Limited | Amino heterocyclic compounds and uses thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0981526B1 (en) * | 1997-05-02 | 2004-02-25 | Dr. Reddy's Laboratories Ltd. | Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| DK1340757T3 (da) * | 2000-11-16 | 2007-02-12 | Sankyo Co | 1-methylcarbapenemderivater |
| EP1403255A4 (en) * | 2001-06-12 | 2005-04-06 | Sumitomo Pharma | RHO KINASE INHIBITORS |
| CN100360130C (zh) * | 2002-04-18 | 2008-01-09 | 先灵公司 | 用作组胺h3拮抗剂的1-(4-哌啶基)苯并咪唑酮 |
| EP1677783A2 (en) * | 2003-10-08 | 2006-07-12 | Nicholas Piramal India Limited | Fibrinogen receptor antagonists and their use |
| DOP2006000009A (es) * | 2005-01-13 | 2006-08-15 | Arena Pharm Inc | Procedimiento para preparar eteres de pirazolo [3,4-d] pirimidina |
| ZA200904857B (en) * | 2007-02-22 | 2010-09-29 | Merck Serono Sa | Quinoxaline compounds and use thereof |
| JP5898962B2 (ja) * | 2012-01-11 | 2016-04-06 | 東京応化工業株式会社 | レジスト組成物及びレジストパターン形成方法 |
| WO2017095758A1 (en) * | 2015-12-01 | 2017-06-08 | Merck Sharp & Dohme Corp. | Homobispiperidinyl derivatives as liver x receptor beta agonists, compositions, and their use |
| GB201712282D0 (en) * | 2017-07-31 | 2017-09-13 | Nodthera Ltd | Selective inhibitors of NLRP3 inflammasome |
| TW201910314A (zh) * | 2017-08-15 | 2019-03-16 | 愛爾蘭商英弗雷佐姆有限公司 | 新穎化合物 |
| CN111902141A (zh) * | 2018-03-26 | 2020-11-06 | C4医药公司 | 用于ikaros降解的羟脑苷脂结合剂 |
| CR20210148A (es) * | 2018-09-21 | 2021-05-18 | Novartis Ag | Compuestos de isoxazol carboxamida y usos de los mismos |
| GB201817038D0 (en) | 2018-10-19 | 2018-12-05 | Inflazome Ltd | Novel processes |
| GB201819083D0 (en) * | 2018-11-23 | 2019-01-09 | Inflazome Ltd | Novel compounds |
-
2022
- 2022-06-23 KR KR1020237044161A patent/KR20240024842A/ko active Pending
- 2022-06-23 CA CA3219597A patent/CA3219597A1/en active Pending
- 2022-06-23 IL IL308071A patent/IL308071A/en unknown
- 2022-06-23 TW TW111123528A patent/TW202317514A/zh unknown
- 2022-06-23 CN CN202280045202.0A patent/CN118019727A/zh active Pending
- 2022-06-23 EP EP22738569.7A patent/EP4359385A2/en active Pending
- 2022-06-23 MX MX2023014547A patent/MX2023014547A/es unknown
- 2022-06-23 WO PCT/EP2022/067126 patent/WO2022268935A2/en not_active Ceased
- 2022-06-23 JP JP2023578919A patent/JP2024524215A/ja active Pending
- 2022-06-23 AR ARP220101651A patent/AR126215A1/es unknown
- 2022-06-23 AU AU2022300325A patent/AU2022300325A1/en active Pending
-
2023
- 2023-12-19 US US18/545,711 patent/US20240150291A1/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH059102A (ja) * | 1990-09-26 | 1993-01-19 | Takeda Chem Ind Ltd | 除草剤 |
| JPH0586055A (ja) * | 1991-01-24 | 1993-04-06 | Ishihara Sangyo Kaisha Ltd | 置換ピリジンスルホンアミド系化合物、それらの製造方法及びそれらを含有する除草剤 |
| WO2010097087A1 (en) * | 2009-02-25 | 2010-09-02 | H. Lundbeck A/S | Catecholamine derivatives and prodrugs thereof |
| WO2019008025A1 (en) * | 2017-07-07 | 2019-01-10 | Inflazome Limited | NOVEL CARBOXAMIDE SULFONAMIDE COMPOUNDS |
| WO2019211463A1 (en) * | 2018-05-04 | 2019-11-07 | Inflazome Limited | Novel compounds |
| WO2020157069A1 (en) * | 2019-01-28 | 2020-08-06 | NodThera Limited | Amino heterocyclic compounds and uses thereof |
| CN111393415A (zh) * | 2020-04-30 | 2020-07-10 | 苏州信诺维医药科技有限公司 | 一种杂芳腈类化合物及其应用 |
Non-Patent Citations (2)
| Title |
|---|
| GIRISH V. AMBULGEKAR ET AL.: "A Novel and Facile Process for the Synthesis of Gliclazide", LETTERS IN ORGANIC CHEMISTRY, vol. 15, JPN6026015970, 2018, pages 760 - 765, ISSN: 0005844555 * |
| TAKASHI IKAWA ET AL.: "Selective N-alkylation of amines using nitriles under hydrogenation conditions: facile synthesis of", ORG. BIOMOL. CHEM, vol. 10, JPN6026015969, 2012, pages 293 - 304, ISSN: 0005844556 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4359385A2 (en) | 2024-05-01 |
| US20240150291A1 (en) | 2024-05-09 |
| IL308071A (en) | 2023-12-01 |
| WO2022268935A2 (en) | 2022-12-29 |
| CN118019727A (zh) | 2024-05-10 |
| KR20240024842A (ko) | 2024-02-26 |
| MX2023014547A (es) | 2024-04-29 |
| AU2022300325A8 (en) | 2023-11-16 |
| AU2022300325A1 (en) | 2023-11-02 |
| CA3219597A1 (en) | 2022-12-29 |
| TW202317514A (zh) | 2023-05-01 |
| WO2022268935A3 (en) | 2023-02-02 |
| AR126215A1 (es) | 2023-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4359385A2 (en) | Process for the preparation of nlrp3 inhibitors | |
| ES2603028T3 (es) | Procedimiento para la preparación de (Z)-alfa-fluoro-beta-amino-acrilaldehídos sustituidos | |
| TR201906366T4 (tr) | Polisiklik-karbamoilpiridon bileşiklerinin sentezi. | |
| CN110139868B (zh) | 制备3-取代的5-氨基-6H-噻唑并[4,5-d]嘧啶-2,7-二酮化合物的方法 | |
| US20240400516A1 (en) | Processes for the preparation of 1,2,3,5,6,7-hexahydro-s-indacene derivataives | |
| JP2026502847A (ja) | Nlrp3阻害剤の調製のためのプロセス | |
| HK40105889A (en) | Process for the preparation of nlrp3 inhibitors | |
| ES2912409T3 (es) | Intermedios y procesos para la preparación de linagliptina y sus sales | |
| JP2016172755A (ja) | 抗ウイルス化合物およびその有用な中間体の調製方法 | |
| HK40112968A (en) | Processes for the preparation of 1,2,3,5,6,7-hexahydro-s-indacene derivatives | |
| WO2025240465A1 (en) | Processes for preparing macrocyclic compounds | |
| IL325043A (en) | Process for the preparation of 1-ethyl-n-((1,2,3,5,6,7-hexahydro-s-indecen-4-yl)carbamoyl)piperidine-4-sulfonamide | |
| HK40012866B (en) | Process for the preparation of 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds | |
| HK40012866A (en) | Process for the preparation of 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds | |
| BR112019013884B1 (pt) | Processo para a preparação de compostos de 5 -amino -6h´ -tiazolo [4,5 -d] pirimidina -2,7 -diona 3 -substituídos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250618 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250618 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260421 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20260716 |